Effects of high-intensity exercises on 13C-nandrolone excretion in trained athletes

Clinical Journal of Sport Medicine

Volumn 15, Issue 3, 2005, Pages 158-166

  Baume, Norbert ^a   Avois, Lidia ^a   Sottas, Pierre Edouard ^a   Dvorak, Jiri ^b   Cauderay, Michel ^c   Mangin, Patrice ^a   Saugy, Martial ^a  

^a UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

^b FIFA MEDICAL CENTRE OF EXCELLENCE   (Switzerland)

^c Hopital Riviera   (Switzerland)

Author keywords

Doping; Excretion; Exercise; Metabolism; Nandrolone; Urine

Indexed keywords

19 NORANDROSTERONE; 19 NORETIOCHOLANOLONE; BETA 2 MICROGLOBULIN; CARBON 13; CREATININE; DRUG METABOLITE; NANDROLONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATHLETE; CONTROLLED STUDY; CREATININE URINE LEVEL; DRUG EXCRETION; DRUG METABOLISM; DRUG URINE LEVEL; EXERCISE; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL;

ADMINISTRATION, ORAL; ADULT; ANABOLIC AGENTS; ANALYSIS OF VARIANCE; DOUBLE-BLIND METHOD; EXERCISE TEST; EXERCISE TOLERANCE; HUMANS; MALE; NANDROLONE; PROBABILITY; PROSPECTIVE STUDIES; RADIOISOTOPES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SPORTS; SUBSTANCE ABUSE DETECTION; URINALYSIS; URINE;

EID: 18744388317     PISSN: 1050642X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jsm.0000158255.78040.ec     Document Type: Article

References (40)

1. Uralets VP, Gillette PA, Latven RK. Occurrence of 19-nordehydro- androsterone/etiocholanolone in nandrolone positive specimens. In: Schänzer W, Geyer H, Gotzmann A, et al, eds. Proceedings of the 14th Cologne Workshop on Dope Analysis: Recent Advances in Doping Analysis (4). Sport und Buch Strauss ed. Cologne: Sport Köln; 1997:35-41.
2. Engel LL, Alexander J, Wheeler M. Urinary metabolites of administered 19-nortestosterone. J Biol Chem. 1958;231:159-164.
3. Schänzer W. Metabolism of anabolic androgenic steroids. Clin Chem. 1996;42:1001-1020.
4. WADA, The World Anti-Doping Agency. WADA Technical Document-TD 2004MRPL, Minimum Required Performance Limits for Detection of Prohibited Substances. Version 1. 2004. Available at: http://www.wada-ama.org.
5. CAS 98/214, B.v/ International Judo Federation (IJF). Sentence of the 17th March 1999, Mars 1999 in the CAS II 1998-2000 Collection of Sentences. Lausanne, Court of Arbitration for Sport: Kluwer Editions, Den Hag; 2001:291ss.
6. CAS 99/A/223, International Tennis Federation (ITF) v/ K. Sentence of the 31th August 1999, in the CAS II 1998-2000 Collection of Sentences. Lausanne, Court of Arbitration for Sport: Kluwer Editions, Den Hag; 2001:345ss.
7. CAS 2001/A/337, B. v/ Fédération Internationale de Natation. Sentence of the 22nd March 2002, in the CAS III 2001-2003 Collection of Sentences. Lausanne, Court of Arbitration for Sport: Kluwer Editions, Den Hag; 2004:206ss.
8. Schmitt N, Flament MM, Goubault C, et al. Nandrolone excretion is not increased by exhaustive exercise in trained athletes. Med Sci Sports Exerc. 2002;34:1436-1439.
9. Le Bizec B, Monteau F, Gaudin I, et al. Evidence for the presence of endogenous 19-norandrosterone in human urine. J Chromatogr B Biomed Sci Appl. 1999;723:157-172.
10. Le Bizec B, Bryand F, Gaudin I, et al. Endogenous nandrolone metabolites in human urine: preliminary results to discriminate between endogenous and exogenous origin. Steroids. 2002;67:105-110.
11. Robinson N, Taroni F, Saugy M, et al. Detection of nandrolone metabolites in urine after a football game in professional and amateur players: a Bayesian comparison. Forensic Sci Int. 2001;122:130-135.
12. Saugy M, Robinson N, Cardis C, et al. Nandrolone metabolites in football players: utility for in and out of competition tests. In: Schänzer W, Geyer H, Gotzmann A, et al, eds. Proceedings of the 17th Cologne Workshop on Dope Analysis: Recent Advances in Doping Analysis (7). Sport und Buch Strauss ed. Cologne: Sport Köln; 1999:95-107.
13. Ciardi M, Ciccoli R, Barbarulo MX et al. Presence of norandrosterone in "normal" urine. In: Schänzer W, Geyer H, Gotzmann A, et al, eds. Proceedings of the 16th Cologne Workshop on Dope Analysis: Recent Advances in Doping Analysis (6). Sport und Buch Strauss ed. Cologne: Sport Köln; 1998:97-104.
14. Van Eenoo P, Delbeke FT, de Jong FH, et al. Endogenous origin of norandrosterone in female urine: indirect evidence for the production of 19-norsteroids as by-products in the conversion from androgen to estrogen. J Steroid Biochem Mol Biol. 2001;78:351-357.
15. Humbert L, L'Hermite M, Vayssette F, et al. Détermination des concentrations physiologiques de la norandrosterone et de la noretiocholanolone, métabolites urinaires de la nandrolone par CPG/SM. Résultats d'une étude multi-centrique. Ann Toxicol Anal. 2000;XII:36-42.
16. Ayotte C, Levesque JF, Cleroux M, et al. Sport nutritional supplements: quality and doping controls. Can J Appl Physiol. 2001;26(suppl):S120-S129.
17. Catlin DH, Leder BZ, Ahrens B, et al. Trace contamination of over-the-counter androstenedione and positive urine test results for a nandrolone metabolite. JAMA. 2000;284:2618-2621.
18. Geyer H, Marek-Engelke U, Wagner A, et al. The analysis of "non-hormonal" nutritional supplements for prohormones. In: Schänzer W, Geyer H, Gotzmann A, et al, eds. Proceedings of the 19th Cologne Workshop on Dope Analysis: Recent Advances in Doping Analysis (9). Sport und Buch Strauss ed. Cologne: Sport Köln; 2001:63-72.
19. Kamber M, Baume N, Saugy M, et al. Nutritional supplements as a source for positive doping cases? Int J Sport Nutr Exerc Metab. 2001;11:258-263.
20. Pipe A, Ayotte C. Nutritional supplements and doping. Clin J Sport Med. 2002;12:245-249.
21. Baume N, Avois L, Schweizer C, et al. [13C]Nandrolone excretion in trained athletes: interindividual variability in metabolism. Clin Chem. 2004;50:355-364.
22. Brue F, Philippe Y, Léger L. Le test de vitesse maximale aérobie derrière cycliste. Med Armees. 1988;16:605-610.
23. Ayotte C, Goudreault D, Lajeunesse A, et al. GC/C/IRMS and GC/MS in "natural" steroids testing. In: Schänzer W, Geyer H, Gotzmann A, et al, eds. Proceedings of the 19th Cologne Workshop on Dope Analysis: Recent Advances in Doping Analysis (9). Sport und Buch Strauss ed. Cologne: Sport Köln; 2001:133-143.
24. Olympic International Committee (IOC). Criteria for reporting low concentrations of anabolic steroids. Olympic Movement Antidoping Code. Appendix 4. Lausanne, Switzerland: Olympic International Committee; 1999:6pp.
25. Vij HS, Howell S. Improving the specific gravity adjustment method for assessing urinary concentrations of toxic substances. Am Ind Hyg Assoc J. 1998;59:375-380.
26. Dehennin L, Bonnaire Y, Plou P. Urinary excretion of 19-norandrosterone of endogenous origin in man: quantitative analysis by gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl. 1999;721:301-307.
27. Donike M, Rauth S, Sample B. Excretion of ephedrine and endogenous steroids under conditions of controlled water intake and water diuresis. In: Donike M, Geyer H, Gotzmann A, et al, eds. Proceedings of the 10th Cologne Workshop on Dope Analysis: Recent Advances in Doping Analysis. Sport und Buch Strauss ed. Cologne: Sport Köln; 1993:163-175.
28. Le Bizec B, Bryand F, Gaudin I, et al. Endogenous nandrolone metabolites in human urine: two-year monitoring of male professional soccer players. J Anal Toxicol. 2002;26:43-47.
29. Marek-Engelke U, Geyer H, Schänzer W. 19-Norandrosterone-criteria for decision making process. In: Schänzer W, Geyer H, Gotzmann A, et al, eds. Proceedings of the 16th Cologne Workshop on Dope Analysis: Recent Advances in Doping Analysis (6). Sport und Buch Strauss ed. Cologne: Sport Köln; 1998:119-129.
30. Le Bizec B, Gaudin I, Pohu A, et al. Identification of endogenous 19-norandrosterone in human urine. In: Schänzer W, Geyer H, Gotzmann A, et al, eds. Proceedings of the 17th Cologne Workshop on Dope Analysis: Recent Advances in Doping Analysis (7). Sport und Buch Strauss ed. Cologne: Sport Köln; 1999:109-119.
31. Reznik Y, Dehennin L, Coffin C, et al. Urinary nandrolone metabolites of endogenous origin in man: a confirmation by output regulation under human chorionic gonadotropin stimulation. J Clin Endocrinol Metab. 2001;86:146-150.
32. De Cock KJ, Delbeke FT, Van Eenoo P, et al. Detection and determination of anabolic steroids in nutritional supplements. J Pharm Biomed Anal. 2001;25:843-852.
33. Galan Martin AM, Marino JI, Garcia de Tiedra MP, et al. Determination of nandrolone and metabolites in urine samples from sedentary persons and sportsmen. J Chromatogr B Biomed Sci Appl. 2001;761:229-236.
34. Gambelunghe C, Sommavilla M, Rossi R. Testing for nandrolone metabolites in urine samples of professional athletes and sedentary subjects by GC/MS/MS analysis. Biomed Chromatogr. 2002;16:508-512.
35. Kohler RM, Lambert MI. Urine nandrolone metabolites: false positive doping test? Br J Sports Med. 2002;36:325-329.
36. Pepin G, Vayssette F, Gaillard Y. Urinary nandrolone metabolites in antidoping control. Ann Pharm Fr. 2001;59:345-349.
37. Schänzer W, Breidbach A, Geyer H, et al. Metabolism of nortestosterone, norandrostenedione and norandrostenediol: identification of 3-hydroxyestr-4-en-17one glucuronide and 3a,16a-dihydroxy-5a-estran-17-one glucuronide and sulphate. In: Schänzer W, Geyer H, Gotzmann A, et al, eds. Proceedings of the 18th Cologne Workshop on Dope Analysis: Recent Advances in Doping Analysis (8). Sport und Buch Strauss ed. Cologne: Sport Köln; 2000:155-174.
38. Kintz P, Cirimele V, Ludes B. Norandrostenolone and noretiocholanolone: metabolite markers. Acta Clin Belg Suppl. 1999;1:68-73.
39. Miyai T, Ogata M. Changes in the concentrations of urinary proteins after physical exercise. Acta Med Okayama. 1990;44:263-266.
40. De Palo EF, Gatti R, Lancerin F, et al. Effects of acute, heavy-resistance exercise on urinary peptide hormone excretion in humans. Clin Chem Lab Med. 2003;41:1308-1313.